Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05789576 · ClinicalTrials.gov registry record · Phase 4

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

A Phase 4 study of Psoriasis, sponsored by Organon and.

Completed
Registry status
Phase 4
Development phase
31
Enrollment target
10
Study locations

NCT05789576 is a Phase 4 study of Psoriasis that has completed, run by Organon and. The registered enrollment target is 31 participants, below the 488-participant average among 125 other Psoriasis trials with a reported enrollment target (94% lower). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05789576, a Phase 4 study of Psoriasis, has completed, sponsored by Organon and.

COMPLETED
Registry status
Phase 4
Development phase
31 participants
Enrollment target
10
Study locations

Study Summary

This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with plaque psoriasis occurring in the head and neck region

Conditions Studied

Psoriasis

Interventions

  • DRUG VTAMA (tapinarof) cream, 1%

Study Locations (10)

Michigan

  • Dermavant Investigative Site - Auburn Hills
  • Dermavant Investigative Site - Detroit

Georgia

  • Dermavant Investigative Site - Macon

Illinois

  • Dermavant Investigative Site - Chicago

Maryland

  • Dermavant Investigative Sites - Rockville

Nevada

  • Dermavant Investigative Site - Las Vegas

New Hampshire

  • Dermavant Investigative Site - Portsmouth

New York

  • Dermavant Investigative Site - Kew Gardens

Ohio

  • Dermavant Investigative Site - Marion

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2023-03-13
Est. Completion 2023-07-19
Phase Phase 4

Sponsor

Organon and

15 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05789576

The ClinicalTrials.gov registry entry for NCT05789576 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 488-participant average among 125 other Psoriasis trials with a reported enrollment target (94% lower). The listed sponsor is Organon and, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Psoriasis appearing as the primary indexed condition, and to 1 intervention - of which VTAMA (tapinarof) cream, 1% is the first listed.

NCT05789576 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Michigan, Georgia, Illinois.

Frequently Asked Questions

What is clinical trial NCT05789576 about?

NCT05789576 is a clinical study titled "A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region". This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with plaque psoriasis occurring in the head and neck region

What is the current status of trial NCT05789576?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2023-03-13. Estimated completion is 2023-07-19.

What conditions does trial NCT05789576 study?

This clinical trial studies the following conditions: Psoriasis.

What interventions are being tested in trial NCT05789576?

The interventions under investigation include: VTAMA (tapinarof) cream, 1% (DRUG).

Who is sponsoring clinical trial NCT05789576?

This trial is sponsored by Organon and, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05789576 being conducted?

This trial has 10 study locations across Georgia, Illinois, Maryland, Michigan, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Psoriasis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Psoriasis

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.